| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/26/1995 | WO1995013822A1 Modified arginine-containing lytic peptides and method of making the same by glyoxylation |
| 05/26/1995 | WO1995013795A1 Hydrophobic preparations |
| 05/26/1995 | WO1995013767A1 Osteogenic product and process |
| 05/26/1995 | WO1995013701A1 Novel fas protein and methods of use thereof |
| 05/26/1995 | WO1995011977A3 A NEW RIBOSOME-INACTIVATING PROTEIN ISOLATED FROM THE PLANT $i(BRYONIA DIOICA) |
| 05/26/1995 | CA2187152A1 Cck-2, a receptor tyrosine kinase |
| 05/26/1995 | CA2176819A1 A method for detection of alterations in the dna mismatch repair pathway |
| 05/26/1995 | CA2176709A1 Method of treating renal disease by administering igf-i and igfbp-3 |
| 05/26/1995 | CA2176708A1 Method of treating neurological disorders |
| 05/26/1995 | CA2176599A1 Use of igf-bp for refolding of igf |
| 05/26/1995 | CA2176577A1 Hydrophobic preparations |
| 05/26/1995 | CA2176575A1 Novel fas protein and methods of use thereof |
| 05/26/1995 | CA2176507A1 Endothelin-converting enzyme |
| 05/26/1995 | CA2176014A1 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting |
| 05/26/1995 | CA2175591A1 Method for purification of a mixture of hydroxamate derivatized protein and native protein |
| 05/26/1995 | CA2174860A1 Myocardial grafts and cellular compositions useful for same |
| 05/26/1995 | CA2109989A1 Polymerized collagen-based anti-fibroid composition |
| 05/24/1995 | EP0654268A1 A method to reverse the phenotype of transformed cells by the transcription factor IRF-1 |
| 05/24/1995 | EP0654144A1 Immunochemical assays for cancer-associated scm recognition factor |
| 05/24/1995 | EP0654092A1 Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes |
| 05/24/1995 | EP0654089A1 Recombinant equine herpesviruses |
| 05/24/1995 | EP0654088A1 Novel flk-2 and analogs |
| 05/24/1995 | EP0654086A1 Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 05/24/1995 | EP0654081A1 Hypoglycosylated recombinant glucosidase oxidases. |
| 05/24/1995 | EP0654080A1 PEPTIDES THAT MIMIC gp120 HIV EPITOPE |
| 05/24/1995 | EP0654077A1 Method and reagent for treatment of animal diseases |
| 05/24/1995 | EP0654075A1 New bacillus thuringiensis strains and their insecticidal proteins |
| 05/24/1995 | EP0654042A1 Amylin muteins |
| 05/24/1995 | EP0654040A1 Pharmaceutical composition containing botulinum b complex |
| 05/24/1995 | EP0654039A1 Process for hemoglobin extraction and purification |
| 05/24/1995 | EP0653943A1 Targeting somatic gene therapy to joints |
| 05/24/1995 | EP0653942A1 Morphogen-induced nerve regeneration and repair |
| 05/24/1995 | EP0653940A1 Glial mitogenic factors, their preparation and use |
| 05/24/1995 | EP0604560A4 Human cyclin e. |
| 05/24/1995 | EP0574394B1 Substances of polypeptide nature useful in human therapy |
| 05/24/1995 | EP0573599B1 Crystallizing biological macromolecules in microgravity |
| 05/24/1995 | EP0569428B1 Method for the diagnosis in vitro of hiv-1 virus infections |
| 05/24/1995 | EP0447468B1 Ancrod proteins, their production and use |
| 05/24/1995 | EP0440709B1 Thrombolytic agents with modified kringle domains |
| 05/24/1995 | EP0398997B1 Genes and their encoded proteins which regulate gene expression of the interleukin-2 receptor and of human lymphotropic retroviruses |
| 05/24/1995 | DE4340111A1 New peptide(s) which inhibit tumour necrosis factor alpha |
| 05/24/1995 | CA2136381A1 Vector vaccines of bovine herpesvirus 1 |
| 05/24/1995 | CA2135587A1 Antitumor antibiotics |
| 05/23/1995 | US5418219 Pharmaceutical composition for treatment of adult respiratory distress syndrome containing human ANP |
| 05/23/1995 | US5418162 Serotonin transporter CDNA |
| 05/23/1995 | US5418160 Cloned cell line expressing rat β3A adrenergic receptor |
| 05/23/1995 | US5418159 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
| 05/23/1995 | US5418153 Brome mosaic virus |
| 05/23/1995 | US5418147 Glycosyl-phosphatidylinositol-specific phospholipase D |
| 05/23/1995 | US5418141 Test articles for performing dry reagent prothrombin time assays |
| 05/23/1995 | US5418137 Flea membrane binding site proteins as screening tools |
| 05/23/1995 | US5418135 Method of inhibiting binding of PDGF to a PDGF receptor by biosynthetic PDGF antagonists |
| 05/23/1995 | US5418130 Phosphonium or ammonium halo-psoralen |
| 05/23/1995 | US5417986 Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres |
| 05/23/1995 | US5417971 Vaccines for Actinobacillus pleuropneumoniae |
| 05/23/1995 | US5417970 Purity |
| 05/23/1995 | US5417959 Functionalized aza-crytand ligands for diagnostic imaging applications |
| 05/23/1995 | EP0673423A4 Viral resistance by plant transformation with a replicase portion of a plant virus genome. |
| 05/23/1995 | CA1335666C Extraction and purification of an anticoagulant principle from the south american leech, haementeria ghilianii |
| 05/23/1995 | CA1335664C Isolates of bacillus thuringiensis having activity against nematodes |
| 05/23/1995 | CA1335662C Peptide derivatives for the treatment and prevention of asthma and the like |
| 05/23/1995 | CA1335661C Non-reverting shigella live vaccines |
| 05/23/1995 | CA1335656C Luminescent chimeric proteins |
| 05/23/1995 | CA1335655C Vaccines and diagnostic assays for haemophilus influenzae |
| 05/23/1995 | CA1335653C Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
| 05/18/1995 | WO1995013397A1 Nucleic acid mutation detection by analysis of sputum |
| 05/18/1995 | WO1995013393A1 Hybrid cytokines |
| 05/18/1995 | WO1995013392A1 Stable cell lines capable of expressing the adeno-associated virus replication gene |
| 05/18/1995 | WO1995013391A1 Method of treatment using, process of preparing, and composition comprising a recombinant hsv-1 |
| 05/18/1995 | WO1995013387A1 Tie-2, a novel receptor tyrosine kinase |
| 05/18/1995 | WO1995013386A2 Tyrosinase-activator protein fusion enzyme |
| 05/18/1995 | WO1995013384A1 Tomato xyloglucan endo-transglycosylase |
| 05/18/1995 | WO1995013378A1 Base-modified enzymatic nucleic acid |
| 05/18/1995 | WO1995013377A1 Episomal expression vector for human gene therapy |
| 05/18/1995 | WO1995013376A1 Gene therapy vector for the treatment of low or defective red blood cell production |
| 05/18/1995 | WO1995013375A1 Tumor suppressor waf1 |
| 05/18/1995 | WO1995013374A2 Human and mouse very low density lipoprotein receptors and methods for use of such receptors |
| 05/18/1995 | WO1995013373A1 Ubiquitous nuclear receptor: compositions and methods |
| 05/18/1995 | WO1995013372A1 Brain-derived membrane-associated crf binding proteins |
| 05/18/1995 | WO1995013371A1 Dna sequences that encode a natural resistance to infection with intracellular parasites |
| 05/18/1995 | WO1995013370A1 Haemophilus transferrin receptor genes |
| 05/18/1995 | WO1995013367A1 Neural axon outgrowth modulators |
| 05/18/1995 | WO1995013366A1 Ectoine synthetase gene |
| 05/18/1995 | WO1995013364A1 In situ modification and manipulation of stem cells of the central nervous system |
| 05/18/1995 | WO1995013363A1 Hematopoietic stem cells from swine cord blood and uses thereof |
| 05/18/1995 | WO1995013302A1 Cathepsin-l-specific inhibitor polypeptide |
| 05/18/1995 | WO1995013301A1 Cross-linked factor viii |
| 05/18/1995 | WO1995013300A1 New factor viii polypeptides |
| 05/18/1995 | WO1995013299A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 05/18/1995 | WO1995013298A1 Agrin receptor |
| 05/18/1995 | WO1995013297A2 Improved immunogenic compositions against human gastrin 17 |
| 05/18/1995 | WO1995013296A1 Receptor specific atrial natriuretic peptides |
| 05/18/1995 | WO1995013295A1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives |
| 05/18/1995 | WO1995013294A1 Cytokines from natural killer or t cells |
| 05/18/1995 | WO1995013293A1 Fas LIGAND, PART THEREOF, AND DNA CODING FOR THE SAME |
| 05/18/1995 | WO1995013292A1 Bcl-2-associated proteins |
| 05/18/1995 | WO1995013291A1 Neuron-glia cell adhesion molecule, ng-cam, in treatment of nerve damage |
| 05/18/1995 | WO1995013288A1 Surface membrane proteins and their effect on immune response |
| 05/18/1995 | WO1995013103A2 Soluble factor stimulation of attachment and hemidesmosome assembly in epithelial cells |
| 05/18/1995 | WO1995013092A1 REESTABLISHMENT OF IFN-η INDUCIBILITY OR CONSTITUTIVE EXPRESSION OF MHC CLASS II IN TUMOR CELLS |